Clarity Capital Partners LLC Has $145,000 Holdings in Enovix Co. (NASDAQ:ENVX)

Clarity Capital Partners LLC trimmed its stake in shares of Enovix Co. (NASDAQ:ENVX) by 90.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,377 shares of the company’s stock after selling 123,962 shares during the period. Clarity Capital Partners LLC’s holdings in Enovix were worth $145,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in ENVX. Prospera Private Wealth LLC acquired a new stake in shares of Enovix in the 3rd quarter valued at about $27,000. Fifth Third Bancorp raised its position in Enovix by 66.7% in the 4th quarter. Fifth Third Bancorp now owns 2,500 shares of the company’s stock valued at $27,000 after buying an additional 1,000 shares during the last quarter. R Squared Ltd acquired a new stake in Enovix in the 4th quarter valued at approximately $64,000. Voisard Asset Management Group Inc. lifted its stake in Enovix by 40.0% in the 3rd quarter. Voisard Asset Management Group Inc. now owns 7,000 shares of the company’s stock valued at $65,000 after acquiring an additional 2,000 shares in the last quarter. Finally, Quest Partners LLC boosted its position in Enovix by 318.5% during the 3rd quarter. Quest Partners LLC now owns 8,270 shares of the company’s stock worth $77,000 after acquiring an additional 6,294 shares during the last quarter. 50.92% of the stock is owned by institutional investors.

Enovix Trading Up 3.1 %

Shares of Enovix stock opened at $10.90 on Thursday. The company has a market capitalization of $1.94 billion, a price-to-earnings ratio of -6.77 and a beta of 1.87. The business has a fifty day simple moving average of $10.89 and a two-hundred day simple moving average of $10.37. Enovix Co. has a 1 year low of $5.70 and a 1 year high of $18.68. The company has a debt-to-equity ratio of 0.99, a current ratio of 3.77 and a quick ratio of 3.61.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ENVX. JPMorgan Chase & Co. cut their price objective on shares of Enovix from $18.00 to $15.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Cantor Fitzgerald restated an “overweight” rating and set a $30.00 price objective on shares of Enovix in a research note on Wednesday, October 30th. Benchmark reaffirmed a “buy” rating and issued a $25.00 target price on shares of Enovix in a research report on Wednesday, October 30th. Finally, Janney Montgomery Scott cut Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price target for the company. in a research report on Thursday, October 31st. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $20.50.

Insider Buying and Selling

In related news, Director Betsy S. Atkins sold 75,000 shares of Enovix stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $9.73, for a total transaction of $729,750.00. Following the completion of the sale, the director now directly owns 99,497 shares of the company’s stock, valued at approximately $968,105.81. This trade represents a 42.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 15.70% of the stock is currently owned by insiders.

About Enovix

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.